Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. reported earnings results for the half year ended June 30, 2023. For the half year, the company reported sales was CNY 423.86 million compared to CNY 245.67 million a year ago. Revenue was CNY 423.86 million compared to CNY 245.67 million a year ago.

Net income was CNY 119.46 million compared to CNY 85.02 million a year ago. Basic earnings per share from continuing operations was CNY 1.1 compared to CNY 0.79 a year ago. Diluted earnings per share from continuing operations was CNY 1.1 compared to CNY 0.79 a year ago.